USANA Health Sciences (USNA) Tops Q2 EPS by 23c, Revenues Beat; Boosts FY18 EPS/Revenues Outlook

Go back to USANA Health Sciences (USNA) Tops Q2 EPS by 23c, Revenues Beat; Boosts FY18 EPS/Revenues Outlook

USANA Health Sciences Inc. (USNA) PT Raised to $135 at Pivotal Research Amid 'Blow-Out' Qtr

July 25, 2018 2:17 PM EDT

Pivotal Research raised its price target on USANA Health Sciences Inc. (NYSE: USNA) to $135.00 (from $100.00) while maintaining a Hold rating following 'blow-out' results and higher guidance.

Analyst Timothy Ramey noted sales were positive in every geography even the perennially-flat Americas & Europe region posted a... More